ObesityNCT07406568
Pilot Trial of the Move Healthier Group
A study testing Move Healthier Intervention in people with Obesity and Overweight, run by Dartmouth-Hitchcock Medical Center at 1 site in United States.
Trial summary
The researchers are developing a new exercise-focused group and are interested in studying whether this group helps people increase their exercise without increasing risk for disordered eating behaviors. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Obesity, Overweight
- What is being tested?
- Move Healthier Intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 10 participants
- Where
- 1 siteUnited States
- Study dates
- 16 Apr 2026to 30 Aug 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Seen for weight loss treatment at DHMC Weight Center within the past year
- Speak, read, \& write English fluently
- Age 18 or older
- Appropriate for group visits (as assessed by referring provider)
Who cannot join
- Meets DSM-5 criteria for an eating disorder based on behavior frequencies reported on baseline EDE-Q
- Report contraindications for unsupervised physical activity on the PAR-Q, or have not been medically cleared by an MD for participation.
Trial locations and contacts
1 site in 1 country.
United States1 site
Dartmouth-Hitchcock Clinics
Lebanon, New Hampshire, 03766
About this study
The researchers are developing a new exercise-focused group and are interested in studying whether this group helps people increase their exercise without increasing risk for disordered eating behaviors.
Read the detailed description
Individuals seeking weight loss are often encouraged to increase their exercise engagement as a health-promoting behavior. However, exercise engagement is often connected directly to caloric intake within weight loss interventions, so it is likely that individuals seeking weight loss are engaging in some level of compensatory exercise even in the absence of other disordered eating symptoms. Compensatory exercise is defined as exercising to "offset" or "make up for" calories consumed with the intent of controlling one's body weight or shape. The researchers are developing a new group to promote healthy exercise and are interested in studying whether this group helps people increase their exercise without increasing risk for compensatory exercise or other disordered eating behaviors.
- Conditions
- Obesity, Overweight
- Being tested
- Move Healthier Intervention
- Keywords
- exercise, physical activity, disordered eating, eating disorder
- Medical subject headings
- Obesity, Overweight, Motor Activity, Feeding and Eating Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Move Healthier InterventionBehavioural
The intervention aims to increase exercise using cognitive and behavioral skills integrated across several treatment manuals including the Physical Activity Cognitively Enhanced (PACE) intervention for healthy exercise promotion in eating disorders, acceptance-based and standard behavioral weight loss manuals, and affect-guided exercise prescriptions.
| Study group | Role | What they receive |
|---|---|---|
| Move Healthier Group Intervention Arm | Experimental | This group-based intervention aims to promote healthy exercise without increasing risk for compensatory exercise or other disordered eating behaviors. Participants will attend 8 weekly 90-minute group intervention sessions via telehealth software. Receives: Behavioral: Move Healthier Intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Objective physical activity
Objective physical activity will be measures as the total number of minutes per week of physical activity measured via Fitbit device worn during waking hours. The Fitbit data will yield a total count of the number of minutes of moderate-to-vigorous physical activity for each week during the intervention period, with higher counts indicating greater levels of activity.
Measured: From enrollment to the end of treatment at 12 weeks
Self-reported physical activity
Participants will also complete self-report measures of physical activity, including the International Physical Activity Questionnaire (IPAQ) and IPAQ-short form at group sessions and study assessments. The IPAQ asks patients to report on their total physical activity engagement over the past 7 days by light, moderate, and vigorous activity categories. The IPAQ yields a total count of the number of minutes of moderate-to-vigorous physical activity over the past week, with higher minutes indicating more activity.
Measured: From enrollment to the end of treatment at 12 weeks
Eating disorder symptoms
ED symptoms will be assessed via the Eating Disorder Examination Questionnaire (EDE-Q 6.0), which asks about ED symptoms over the past month (28 days). Compensatory exercise engagement will be assessed via an item asking, "Over the past 28 days, how many times have you exercised to "make up for" a binge-eating episode, and compulsive exercise will be assessed using the item "...how many times have you felt driven/compelled to exercise?" EDE-Q items are averages to calculate a total score ranging from 0-6, with higher scores indicating higher levels of eating pathology.
Measured: Baseline and post-intervention (week 12)
Secondary outcomes (3)
Weight bias internalization
Internalized weight stigma will be measured using the Weight Bias Internalization Scale (WBIS). The WBIS comprises 11 items measuring self-directed weight bias and has shown excellent convergent and divergent validity within the population of interest. The WBIS items are averaged to yield a total score ranging from 1-7, with higher scores reflecting higher internalized weight bias.
Measured: baseline and post-intervention (week 12)
intervention acceptability
Participants will complete qualitative interviews at post-treatment to provide feedback on group format, acceptability, utility, etc. Qualitative analysis of these interview transcripts will elucidate themes related to group acceptability.
Measured: post-intervention (week 12)
intervention feasibility
Feasibility will be measured via group attendance rates across the 12 sessions.
Measured: post-intervention (week 12)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Feb 2026
- Study start16 Apr 2026
- Primary completion30 Aug 2026
- Study completion30 Aug 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ObesityStudies of the same condition, open and under way.
- More trials run by Dartmouth-Hitchcock Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 10 participants (actual)
Sponsor and investigators
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Elizabeth.W.Lampe, Dartmouth-Hitchcock Medical Center
- Investigators
- Jessica Salwen-Deremer, PhD, Study director, Dartmouth HealthElizabeth Lampe, PhD, Principal investigator, Dartmouth Health
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07406568
- Sponsor's protocol ID
- STUDY02003218
- Status last verified
- Sep 2026
- First submitted
- 13 Jan 2026
- Last updated
- 16 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Pilot Trial of the Move Healthier Group
- ClinicalTrials.gov ID
- NCT07406568
- Acronym / sponsor ID
- STUDY02003218
- Conditions
- Obesity, Overweight
- Keywords
- exercise, physical activity, disordered eating, eating disorder
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 10 participants (actual)
- Lead sponsor
- Dartmouth-Hitchcock Medical CenterUniversity, hospital or other
- Study start
- 16 Apr 2026 (actual)
- Primary completion
- 30 Aug 2026 (actual)
- Study completion
- 30 Aug 2026 (actual)
- First posted
- 12 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The researchers are developing a new exercise-focused group and are interested in studying whether this group helps people increase their exercise without increasing risk for disordered eating behaviors.
Detailed description
Individuals seeking weight loss are often encouraged to increase their exercise engagement as a health-promoting behavior. However, exercise engagement is often connected directly to caloric intake within weight loss interventions, so it is likely that individuals seeking weight loss are engaging in some level of compensatory exercise even in the absence of other disordered eating symptoms. Compensatory exercise is defined as exercising to "offset" or "make up for" calories consumed with the intent of controlling one's body weight or shape. The researchers are developing a new group to promote healthy exercise and are interested in studying whether this group helps people increase their exercise without increasing risk for compensatory exercise or other disordered eating behaviors.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Move Healthier Group Intervention Arm | Experimental | Behavioral: Move Healthier InterventionThis group-based intervention aims to promote healthy exercise without increasing risk for compensatory exercise or other disordered eating behaviors. Participants will attend 8 weekly 90-minute group intervention sessions via telehealth software. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Seen for weight loss treatment at DHMC Weight Center within the past year
- Speak, read, \& write English fluently
- Age 18 or older
- Appropriate for group visits (as assessed by referring provider)
Key exclusion criteria (2 listed)
- Meets DSM-5 criteria for an eating disorder based on behavior frequencies reported on baseline EDE-Q
- Report contraindications for unsupervised physical activity on the PAR-Q, or have not been medically cleared by an MD for participation.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Move Healthier InterventionThe intervention aims to increase exercise using cognitive and behavioral skills integrated across several treatment manuals including the Physical Activity Cognitively Enhanced (PACE) intervention for healthy exercise promotion in eating disorders, acceptance-based and standard behavioral weight loss manuals, and affect-guided exercise prescriptions. | Behavioural | Move Healthier Group Intervention Arm |
Primary outcome
Objective physical activity
Time frame: From enrollment to the end of treatment at 12 weeks
Objective physical activity will be measures as the total number of minutes per week of physical activity measured via Fitbit device worn during waking hours. The Fitbit data will yield a total count of the number of minutes of moderate-to-vigorous physical activity for each week during the intervention period, with higher counts indicating greater levels of activity.
Self-reported physical activity
Time frame: From enrollment to the end of treatment at 12 weeks
Participants will also complete self-report measures of physical activity, including the International Physical Activity Questionnaire (IPAQ) and IPAQ-short form at group sessions and study assessments. The IPAQ asks patients to report on their total physical activity engagement over the past 7 days by light, moderate, and vigorous activity categories. The IPAQ yields a total count of the number of minutes of moderate-to-vigorous physical activity over the past week, with higher minutes indicating more activity.
Eating disorder symptoms
Time frame: Baseline and post-intervention (week 12)
ED symptoms will be assessed via the Eating Disorder Examination Questionnaire (EDE-Q 6.0), which asks about ED symptoms over the past month (28 days). Compensatory exercise engagement will be assessed via an item asking, "Over the past 28 days, how many times have you exercised to "make up for" a binge-eating episode, and compulsive exercise will be assessed using the item "...how many times have you felt driven/compelled to exercise?" EDE-Q items are averages to calculate a total score ranging from 0-6, with higher scores indicating higher levels of eating pathology.
3 secondary outcomes
Weight bias internalization
Time frame: baseline and post-intervention (week 12)
intervention acceptability
Time frame: post-intervention (week 12)
intervention feasibility
Time frame: post-intervention (week 12)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Sep 2026.
- Individual participant dataSharing planned: No
Related trials for Obesity
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
Active, not recruitingPhase 4
Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders
Metabolic Abnormalities, Obesity & Overweight
Recruiting
Exercise Training and Vitamin D Metabolism
Obesity & Overweight, Vitamin D
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Active, not recruiting
Effect of Probiotics on Insulin Sensitivity in Overweight and Obese Pregnancy
Obesity & Overweight, Gestational Diabetes Mellitus (GDM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jessica Salwen-Deremer, PhD study director
Dartmouth Health
Elizabeth Lampe, PhD principal investigator
Dartmouth Health
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Move Healthier Intervention in people with Obesity and Overweight, run by Dartmouth-Hitchcock Medical Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Objective physical activity (time frame: From enrollment to the end of treatment at 12 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2026.